Design and study of telomerase inhibitors based on G-quadruplex ligands

Biopolymers and Cell

Volumn 29, Issue 3, 2013, Pages 169-176

  Negrutska, V V ^a   Dubey, L V ^a   Ilchenko, M M ^a   Dubey, I Ya ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

Author keywords

Antitumor agents; G quadruplex; Molecular modeling; Porphyrins; Telomerase; TRAP

Indexed keywords

ACRIDONE DERIVATIVE; CYANINE DYE; GUANINE QUADRUPLEX; OLIGONUCLEOTIDE; PHENAZINE DERIVATIVE; PHEOPHORBIDE; PORPHYRIN DERIVATIVE; QUARFLOXIN; TELOMERASE INHIBITOR; TELOMESTATIN; ZINC DERIVATIVE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; DRUG DESIGN; FLUORESCENCE SPECTROSCOPY; HUMAN; INTERCALATION COMPLEX; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MODEL; NONHUMAN; PHOTODYNAMICS; POLYMERASE CHAIN REACTION; PROTEIN DNA INTERACTION; QUANTUM CHEMISTRY; TELOMERE;

EID: 84879973952     PISSN: 02337657     EISSN: 19936842     Source Type: Journal    
DOI: 10.7124/bc.000817     Document Type: Review

References (39)

1. Harley C. B. Telomerase and cancer therapeutics. Nat. Rev. Cancer. 2008. 8, N 3. P. 167-179.
2. Rudolph K. L. Telomeres and telomerase in aging, disease, and cancer. Berlin-Heidelberg: Springer, 2010. 330 p.
3. Tian X., Chen B., Liu X. Telomere and telomerase as targets for cancer therapy. Appl. Biochem. Biotechnol. 2010. 160, N 5. P. 1460-1472.
4. Ruden M., Puri N. Novel anticancer therapeutics targeting telomerase. Cancer Treat. Rev. 2012. 39, N 5. P. 444-456.
5. De Cian A., Lacroix L., Douarre C., Temime-Smaali N., Trentesaux C., Riou J. F., Mergny J. L. Targeting telomeres and telomerase. Biochimie. 2008. 90, N 1. P. 131-155.
6. Tarkanyi I., Aradi J. Pharmacological intervention strategies for affecting telomerase activity. further prospects to treat cancer and degenerative diseases. Biochimie. 2008. 90, N 1. P. 156-172.
7. Xu Y. Chemistry in human telomere biology: structure, function and targeting of telomere DNA/RNA. Chem. Soc. Rev. 2011. 40, N 5. P. 2719-2740.
8. Telomerase Inhibition: Strategies and Protocols. Eds L. Andrews, T. O. Tollefsbol. Totowa: Humana press, 2011. 203 p.
9. Xu Y., Komiyama M. Structure, function and targeting of human telomere RNA. Methods. 2012. 57, N 1. P. 100-105.
10. Neidle S. Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer. FEBS J. 2010. 277, N 5. P. 1118-1125.
11. Collie G. W., Parkinson G. N. The application of DNA and RNA G-quadruplexes to therapeutic medicines. Chem. Soc. Rev. 2011. 40, N 12. P. 5867-5892.
12. Kaushik M., Kaushik S., Bansal A., Saxena S., Kukreti S. Structural diversity and specific recognition of four stranded G-quad-ruplex DNA. Curr. Mol. Med. 2011. 11, N 9. P. 744-769.
13. Duchler M. G-quadruplexes: targets and tools in anticancer drug design. J. Drug Target. 2012. 20, N 5. P. 389-400.
14. Monchaud D., Teulade-Fichou M. P. A hitchhiker’s guide to G-quadruplex ligands. Org. Biomol. Chem. 2008. 6, N 4. P. 627-636.
15. Vy Thi Le T., Han S., Chae J., Park H. J. G-quadruplex binding ligands: from naturally occurring to rationally designed molecules. Curr. Pharm. Des. 2012. 18, N 14. P. 1948-1972.
16. Paul A., Bhattacharya S. Chemistry and biology of DNA-binding small molecules. Curr. Sci. 2012. 102, N 2. P. 212-231.
17. Gomez D., Mergny J. L., Riou J. F. Detection of telomerase inhibitors based on G-quadruplex ligands by a modified telomeric repeat amplification protocol assay. Cancer Res. 2002. 62, N 12. P. 3365-3368.
18. Xin H. Telomeric repeat amplification protocol: measuring the activity of the telomerase. Methods Mol. Biol. 2011. 735. P. 107-111.
19. Palchykovska L. G., Alexeeva I. V., Negrutska V. V., Kostyuk Yu. K., Indychenko T. M., Kostenko O. M., Kryvorotenko D. V., Shved A. D., Dubey I. Ya. Inhibition in vitro transcription by 2-arylidene derivatives of thiazolo[3,2-]benzimidazol-3(2H)-one. Biopolym. Cell. 2010. 26, N 6. P. 508-511.
20. Ryazanova O. A., Voloshin I. M, Dubey I. Ya., Dubey L. V., Zozu- lya V. N. Spectroscopic studies on binding of cationic Pheophorbide-a derivative to model polynucleotides. IFMBE Proceed- ings. Berlin-Heidelberg: Springer, 2008. Vol. 20. P. 397-400.
21. Ryazanova O., Voloshin I., Dubey I., Dubey L., Zozulya V. Fluo-rescent studies on cooperative binding of cationic Pheophorbide-a derivative to polyphosphate. Ann. N. Y. Acad. Sci. 2008. 1130. P. 293-299.
22. Ryazanova O. A., Voloshin I. M., Dubey L. V., Zozulya V. N. Spectroscopic investigation on binding of the methyl ester of Pheophorbide-a to synthetic polynucleotides and DNA. Biophys. Bull. (Kharkiv). 2009. 23, N 2. P. 20-29.
23. Dubey I., Pratviel G., Meunier B. Preparation of cationic nonmetallated or zinc-porphyrin-oligonucleotide fluorescent conjugates. Compt. Rend. Acad. Sci. (Paris), Ser. II C. 1998. 1, N 4. P. 259-267.
24. Dubey I., Pratviel G., Meunier B. Modification of the thiourea linkage of fluorescein-oligonucleotide conjugate to a guanidinium motif during ammonia deprotection. Bioconjug. Chem. 1998. 9, N 5. P. 627-632.
25. Dubey I., Pratviel G., Meunier B. Synthesis and DNA cleavage of 2'-O-amino-linked metalloporphyrin-oligonucleotide conjugates. J. Chem. Soc. Perkin 1. 2000. 18. P. 3088-3095.
26. Maraval A., Franco S., Vialas C., Pratviel G., Blasco M. A., Meunier B. Porphyrin-aminoquinoline conjugates as telomerase inhibitors. Org. Biomol. Chem. 2003. 1, N 6. P. 921-927.
27. Zozulya V., Shcherbakova A., Dubey I. Calculating helix-to-coil transitions of duplexes formed by phenazine-conjugated oligonucleotide, using fluorescence melting data. J. Fluoresc. 2000. 10, N 1. P. 49-54.
28. Zozulya V., Blagoi Yu, Dubey I., Fedoryak D., Makitruk V., Rya- zanova O., Shcherbakova A. Anchorage of an oligonucleotide hybridization by a tethered phenazine nucleoside analogue. Biopolymers. 2003. 72, N 4. P. 264-273.
29. Skripal’ I. H., Babichev V. V., Panchenko L. P., Iegorov O. V., Korobkova K. S., Dubey I. Y., Fedoryak D. M., Shalamay A. S. Antisignature oligonucleotides and their analogs as inhibitors of mollicutes-cofactors of HIV. Mikrobiol. Z. 1997. 59, N 2. P. 3-11.
30. Dubey L., Ryazanova O., Zozulya V., Fedoryak D., Dubey I. Postsynthetic modification of oligonucleotides with imidazophe-nazine dye and its effect on duplex stability. Nucleosides Nuc- leotides Nucleic Acids. 2011. 30, N 7-8. P. 585-596.
31. Ryazanova O., Dubey L., Dubey I., Zozulya V. Spectroscopic study on the effect of imidazophenazine tethered to 5'-end of pentadecathymidilate on stability of poly(dA)·(dT)15 duplex. J. Fluoresc. 2012. 22, N 6. P. 1431-1439.
32. Dubey L. V., Ilchenko M. M., Zozulya V. N., Ryazanova O. A., Pogrebnoy P. V., Dubey I. Ya. Synthesis, structure and antipro-liferative activity of cationic porphyrin-imidazophenazine conjugate. Int. Rev. Biophys. Chem. 2011. 2, N 4. P. 147-152.
33. Zozulya V., Ryazanova O., Voloshin I., Glamazda A., Karachevt-sev V., Dubey I., Pratviel G. Spectroscopic studies on interactions of a tricationic porphyrin derivative with polynucleotides. 12th Eur. Conf. «Spectroscopy of Biological Molecules» (Bobigny, France, 1-6 Sept. 2007): Abstracts. Bobigny, 2007. P. 129.
34. Zozulya V. N., Ryazanova O. A., Voloshin I. M., Glamazda A. Yu., Karachevtsev V. A., Dubey L. V., Dubey I. Ya. Spectroscopic stu- dies on interactions of tricationic porphyrin derivative with po- lynucleotides. V Congress of Ukr. Biophys. Soc.: Abstract book (Lutsk-Svityaz, 22-25 June 2011). Lutsk, 2011. P. 16.
35. Zozulya V., Ryazanova O., Voloshin I., Dubey L., Dubey I. Spectroscopic studies on binding of porphyrin-phenazine conjugate to G- quadruplexes formed by poly(G). Int. Conf. «Conformational Diversity and Application of G-Quadruplexes» (Barcelona, Spain, October 6-8 2012): Abstract. Barcelona, 2012. P. 114-115.
36. Zozulya V. N., Ryazanova O. A., Voloshin I. M., Dubey L. V., Dubey I. Ya. Spectroscopic studies on binding of porphyrinphenazine conjugate to intramolecular G-quadruplex formed by 22-mer oligonucleotide. Int. Rev. Biophys. Chem. 2011. 2, N 4. P. 112-119.
37. Negrutska V. V., Dubey L. V., Kuziv Ia. B., Dubey I. Ya. In vitro telomerase inhibition by cationic porphyrin derivatives. III Int. Symp. «Intracellular Signalling and Bioactive Molecules Design» (Lviv, Ukraine, 17-23 September 2012): Abstract. Lviv, 2012. P. 144.
38. Ilchenko M. M., Dubey I. Y. Density functional study of the structure of guanine octets in aqueous medium. Int. Rev. Biophys. Chem. 2011. 2, N 3. P. 82-86.
39. Vreven T., Morokuma K. Hybrid methods: ONIOM(QM:MM) and QM/MM. Annu. Rep. Comp. Chem. 2006. 2. P. 35-51.